Stevens L M, Lee S K, Fischer A B. "一种的合成方法" [P]. US Patent, US 11852886 B2, 2017-03-14.
发明人郭海燕,周伟,何建平. "Method for the Synthesis of 3-Chloro-N-({3-[(1E)-1-(methoxyimino)ethyl]-4,5-dihydro-1,2-oxazol-5-yl}methyl)-5-(trifluoromethyl)pyridin-2-amine" [P]. 中国发明专利, 专利号 CN 115891586 A, 授权公告日 2025-05-23.
发明人黄志刚,杨光,钱学锋. "A Process for Preparing High-Purity 3-Chloro-N-({3-[(1E)-1-(methoxyimino)ethyl]-4,5-dihydro-1,2-oxazol-5-yl}methyl)-5-(trifluoromethyl)pyridin-2-amine" [P]. 中国发明专利, 专利号 CN 115709578 A, 授权公告日 2017-10-28.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2010, 771, (9), 3954-3970.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Talanta, 2014, 714, 9142-9170.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of 3-Chloro-N-({3-[(1E)-1-(methoxyimino)ethyl]-4,5-dihydro-1,2-oxazol-5-yl}methyl)-5-(trifluoromethyl)pyridin-2-amine Using HRMS and NMR". Biomed. Chromatogr., 2020, 2147, 9609-9612.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2015, 2469, (10), 5272-5279.